Moderna, Inc. 2025-2026 Proxy Voting Records

Description as filed by funds: To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Abbas Hussain

Moderna, Inc.’s own tally for this item (“Elect Director: Abbas Hussain”): 256,398,374 for, 4,015,044 against, per its Form 8-K filed May 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “By the vote reflected below, the Company's stockholders elected each of the following individuals to serve as a Class II director for a three-year term expiring at the Company's 2029 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified, or such dire…”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 135,696,750 for, 221,931 against, 48,002 abstained, 265 not voted.

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

Description as filed by funds: To elect two Class II director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Sandra Horning, M.D.

Moderna, Inc.’s own tally for this item (“Elect Director: Sandra Horning, M.D.”): 210,914,932 for, 49,357,015 against, per its Form 8-K filed May 11, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “By the vote reflected below, the Company's stockholders elected each of the following individuals to serve as a Class II director for a three-year term expiring at the Company's 2029 Annual Meeting of Stockholders and until his or her respective successor is duly elected and qualified, or such dire…”
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 115,809,901 for, 20,108,779 against, 48,002 abstained, 265 not voted.

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

Description as filed by funds: To approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Option Exchange Proposal (the "Adjournment Proposal").

Moderna, Inc.’s own tally for this item (“2. Approval of adjournment of the Special Meeting to a later date or dates, if necessary”): 223,991,059 for, 13,198,386 against — passed, per its Form 8-K filed November 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there were insufficient votes for, or otherwise in connection with, the approval of the Option Ex…”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 104 asset managers below reported 85,780,597 for, 6,741,664 against, 24,589 abstained, 273 not voted.

Showing the 25 largest of 104 asset managers. See all 104 in the interactive database.

The 4 asset managers below reported 115,320 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Description as filed by funds: To approve a one-time stock option exchange program for non-Executive Committee employees of Moderna, Inc. (the "Option Exchange Proposal")

Moderna, Inc.’s own tally for this item (“1. Approval of a one-time stock option exchange program for non-Executive Committee employees”): 231,049,158 for, 6,167,159 against — passed, per its Form 8-K filed November 13, 2025 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 1: Approval of a one-time stock option exchange program for non-Executive Committee employees”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 114 asset managers below reported 90,451,619 for, 2,226,957 against, 273 not voted.

Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

Moderna, Inc.’s own tally for this item (“2. Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers”): 169,401,841 for, 90,761,924 against — passed, per its Form 8-K filed May 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved, on an advisory basis, the compensation of the named executive officers.”
Support: 65% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Moderna, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Say on pay” (2 managers, 100 for, 461 against, 461 1 year).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 111 managers: 76,222,343 for, 59,696,066 against, 48,002 abstained, 265 not voted. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 597 managers: 91,128,682 for, 54,713,261 against, 172,213 abstained, 13,187 not voted, 255,332 1 year, 77,427 mixed, 45 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: To approve, on a non-binding, advisory basis, the frequency of future non-binding advisory votes to approve the compensation of our named executive officers.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

Fund voting reports, all 109 managers: 32,197 for, 48,002 abstained, 265 not voted, 135,589,282 1 year, 63,560 3 year, 40,383 unknown. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports, all 556 managers: 32,403 for, 254,058 against, 12,781 abstained, 13,187 not voted, 140,368,122 1 year, 401,523 3 year, 3,196 2 year, 781 unknown. Showing the 25 largest; see all in the interactive database.

Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2026.

Moderna, Inc.’s own tally for this item (“4. Ratification of appointment of independent registered public accounting firm”): 298,823,277 for, 3,406,479 against — passed, per its Form 8-K filed May 11, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, with the votes cast as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 113 asset managers below reported 135,712,778 for, 12,968 against, 48,001 abstained, 265 not voted.

Showing the 25 largest of 113 asset managers. See all 113 in the interactive database.